Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapy
Description
Convalescent plasma has been extensively tested during the COVID-19 pandemic as a transfusion product. Similarly, monoclonal antibodies have been largely administered either intravenously or intramuscularly. Nevertheless, when used against a
